Hamad Abdel Hadi - Infectious Diseases

Author Information

Dr. Hamad Abdel Hadi is a distinguished researcher affiliated with the Communicable Diseases Centre, Infectious Disease Division at Hamad Medical Corporation in Doha, Qatar. His work primarily focuses on infectious diseases, with a particular interest in antimicrobial resistance and the clinical management of complex infections.

Research Contributions

Dr. Hadi has made significant contributions to the field of infectious diseases, particularly in understanding the mechanisms of antimicrobial resistance. His research includes examining the resistance of Pseudomonas aeruginosa to various antibiotic compounds, exploring the use of Remdesivir in COVID-19 patients with chronic kidney disease, and evaluating antibiotic prescribing practices during the COVID-19 pandemic. Additionally, his work has delved into the epidemiology of infectious diseases in the Middle East and North Africa, providing valuable insights into regional health challenges.

Aliases

Dr. Hamad Abdel Hadi is also known by the aliases Hamad A. Hadi and Hamad Abdel Hadi in various publications and professional platforms.

Publication and Citation Metrics

Metric	Value
Total Papers	22
Total Citations	193
h-index	4

Publications:

Association of blaVIM-2, blaPDC-35, blaOXA-10, blaOXA-488 and blaVEB-9 β-Lactamase Genes with Resistance to Ceftazidime–Avibactam and Ceftolozane–Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa

DOI: 10.3390/antibiotics11020130

Year: 2022

Remdesivir for Covid-19 pneumonia in patients with severe chronic kidney disease: Case series and review of the literature

DOI: 10.22541/au.164120188.85772322/v1

Year: 2022

Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against ESBL-producing Enterobacterales isolated from Intensive Care Units from Qatar

DOI: 10.5001/omj.2022.89

Year: 2022

Isolated pulmonary cryptococcosis in a patient with Crohn's disease treated with infliximab: A case report and literature review

DOI: 10.1016/j.rmcr.2021.101459

Year: 2021

Challenges in the diagnosis of pulmonary mucormycosis in a diabetic with a review of literature

DOI: 10.1016/j.rmcr.2021.101474

Year: 2021

Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region

DOI: 10.1128/mSphere.00202-21

Year: 2021

192. Epidemiology, Microbiological Characteristics and Clinical Outcomes of Invasive Blood Stream Infections of Group B Streptococcal Isolates From Qatar

DOI: 10.1093/ofid/ofab466.394

Year: 2021

A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic

DOI: 10.3389/fimmu.2021.631139

Year: 2021

Antibiotics Prescribing in Intensive Care Settings during the COVID-19 Era: A Systematic Review

DOI: 10.3390/antibiotics10080935

Year: 2021

Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar

DOI: 10.1080/07853890.2021.2012588

Year: 2021

How Can Schools and Universities Incorporate Infectious Disease Education?

What are Zoonoses?

How are Sporozoites Detected?

What Diseases are Caused by Apicomplexan Parasites?

How is Parasite DNA Important in Infectious Diseases?

Which Diseases Spread Through Airborne Transmission?

How Can Bacterial Infections Be Prevented?

How is Avian Influenza Transmitted?

How do Infectious Diseases Contribute to Mortality?

How are Adenoviruses Transmitted?

Partnered Content Networks

Relevant Topics